Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Aug 15;195(4):1359-63.
doi: 10.4049/jimmunol.1500264. Epub 2015 Jul 15.

Cutting Edge: A Natural Antisense Transcript, AS-IL1α, Controls Inducible Transcription of the Proinflammatory Cytokine IL-1α

Affiliations

Cutting Edge: A Natural Antisense Transcript, AS-IL1α, Controls Inducible Transcription of the Proinflammatory Cytokine IL-1α

Jennie Chan et al. J Immunol. .

Abstract

Natural antisense transcripts (NATs) are a class of long noncoding RNAs (lncRNAs) that are complementary to other protein-coding genes. Although thousands of NATs are encoded by mammalian genomes, their functions in innate immunity are unknown. In this study, we identified and characterized a novel NAT, AS-IL1α, which is partially complementary to IL-1α. Similar to IL-1α, AS-IL1α is expressed at low levels in resting macrophages and is induced following infection with Listeria monocytogenes or stimulation with TLR ligands (Pam3CSK4, LPS, polyinosinic-polycytidylic acid). Inducible expression of IL-1α mRNA and protein were significantly reduced in macrophages expressing shRNA that target AS-IL1α. AS-IL1α is located in the nucleus and did not alter the stability of IL-1α mRNA. Instead, AS-IL1α was required for the recruitment of RNA polymerase II to the IL-1α promoter. In summary, our studies identify AS-IL1α as an important regulator of IL-1α transcription during the innate immune response.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Identification of AS-IL1α. (A) Circos plot showing differentially expressed genes in splenocytes from L. Monocytogenes infected mice. Chromosomes are indicated on the outer tracks. The middle track shows log2 fold-change values for all lncRNAs and AS-IL1α (colored red). The inner track shows log2 fold-change values for protein-coding genes, with immune genes colored in red. (B) AS-IL1α schematic in murine macrophages. AS-IL1α chromosomal localization overlaps with IL-1α protein coding gene on chromosome 2 indicated by vertical bar. (C) Macrophages infected with L. Monocytogenes for 3 hours at MOI 5 and MOI 10. Data were normalized with GAPDH, fold change calculated and are representative of 2 independent experiments (D) Polysome profiling of GAPDH, IL-1α and AS-IL1α transcripts. Immortalized macrophages were stimulated with LPS and either treated with cycloheximide alone, or harringtonine prior to cycloheximide treatment to determine translational potential of AS-IL1α.
Figure 2
Figure 2
Inducibility of AS-IL1α by TLR ligands. (A) A schematic of AS-IL1α and IL-1α and qRT-PCR primers for experiments B-E (not scaled). (B) LPS, Pam3CSK4, Poly(I:C) or ISD were stimulated on iBMDMs for 0, 1, 2, or 6 hours and AS-IL1α expression was measured by qRT-PCR (C) Wildtype and IL-1α knockout macrophages were stimulated with LPS for 6 hours. AS-IL1α expression was induced even in the absence of IL-1α. (D) WT and MyD88/Trif double knockout macrophages were not-treated (NT), LPS, Pam3CSK4 or Poly(I:C) treated for 6 hours. AS-IL1α expression was measured by qRT-PCR. (**** p<0.0001, ** p<0.01 by one way ANOVA). (E) An NF-κB inhibitor, Bay11-7082, was treated on cells 1 hour prior to LPS stimulation (6 hours), and AS-IL1α expression was measured by qRT-PCR. (*** p<0.001 by two-tailed T test). Data were normalized to GAPDH, fold change calculated and are means + S.D. representative of 3 replicates.
Figure 3
Figure 3
AS-IL1α regulates IL-1α expression. (A) shRNA 1 and shRNA 2 target AS-IL1α in red regions (not to scale) that do not overlap with IL-1α. (B) AS-IL1α RNA levels (qRT-PCR) were reduced in both shRNA 1 and shRNA 2 cell lines. shRNA GFP is a control that targets the GFP gene. (C) IL-1α mRNA levels (qRT-PCR) were reduced in shRNA 1 and shRNA 2 cell lines. (D) IL-1α p33 protein expression (Western blot) was decreased in shRNA 1 and shRNA 2 cell lines stimulated with LPS. β-actin was used as a loading control. (E) Nanostring analysis was performed on the cell lines to determine if knocking down AS-IL1α affects the expression of other immune genes. Immune genes with a 15-fold change in expression following LPS stimulation are shown. For B and C, P-values were <0.0001**** (one way ANOVA) and data were calculated as fold-change relative to GAPDH and are representative of 3 biological replicates.
Figure 4
Figure 4
AS-IL1α regulates IL-1α transcription. (A) Localization of AS-IL1α in LPS-induced iBMDMs. Cytosolic and nuclear fractions were separated via a sucrose gradient and qRT-PCR was performed on fractionated RNA. Gapdh (cytosolic), IL-1α (cytosolic) and 7SK (nuclear) were also measured as controls. Data is represented as % cytosolic or % nuclear fractions over cytosolic+nuclear (100%) total RNA. (B) qRT-PCR was performed on shRNA-GFP and two AS-IL1α KD cell lines. Schematic shows regions to be amplified by primers in mature IL-1α mRNA (exon-exon junction), and pre-spliced IL-1α mRNA. RNA levels shown as a percentage of expression in shRNA-GFP (representative of 2 experiments). (C) A comparison of poly-d(T) and random hexamer priming for Reverse Transcription to an AS-IL1α specific primer to demonstrate specificity of amplified region prior to qRT-PCR. (D) Chromatin immunoprecipitation (ChIP) on the cell lines were performed. Antibodies against RNAPII or IgG isotype control were used. Regions of the IL-1α gene, near the transcription start site (+22) were measured for RNAPII binding. RNAPII recruitment did not decrease at the CXCL10 (IP10) or Gapdh promoter. Data were normalized with Input chromatin before immunoprecipitation. (p<0.05 by two-tailed T test). Same comparisons were made for CXCL10 and GAPDH. Bars without * are not significant.

Similar articles

Cited by

References

    1. Consortium, R. G. E. R. G. and G. S. G. (Genome N. P. C. G. and the F. Antisense Transcription in the Mammalian Transcriptome. Science (80-.) 2005;309:1564–1566. - PubMed
    1. Derrien T, Johnson R, Bussotti G, Tanzer A, Djebali S, Tilgner H, Guernec G, Martin D, Merkel A, Knowles DG, Lagarde J, Veeravalli L, Ruan X, Ruan Y, Lassmann T, Carninci P, Brown JB, Lipovich L, Gonzalez JM, Thomas M, Davis CA, Shiekhattar R, Gingeras TR, Hubbard TJ, Notredame C, Harrow J, Guigo R. The GENCODE v7 catalog of human long noncoding RNAs: Analysis of their gene structure, evolution, and expression. Genome Res. 2012;22:1775–1789. - PMC - PubMed
    1. Carpenter S, Aiello D, Atianand MK, Ricci EP, Gandhi P, Hall LL, Byron M, Monks B, Henry-Bezy M, Lawrence JB, O’Neill LAJ, Moore MJ, Caffrey DR, Fitzgerald KA. A long noncoding RNA mediates both activation and repression of immune response genes. Science (80.) 2013;341:789–792. - PMC - PubMed
    1. Rinn JL, Chang HY. Genome Regulation by Long Noncoding RNAs. Annu. Rev. Biochem. 2012;81:145–166. - PMC - PubMed
    1. Carpenter S, Fitzgerald KA. Transcription of inflammatory genes: long noncoding RNA and beyond. J. Interferon Cytokine Res. 2015;35:79–88. - PMC - PubMed

Publication types